The Japan hemostats market size is anticipated to reach USD 292.6 million by 2030 and is anticipated to expand at a CAGR of 6.40% from 2024 to 2030. The increasing geriatric population and the rising competition among key industry participants are the major factors contributing to the market growth. The companies operating in the industry such as Johnson & Johnson Services, Inc. and Baxter are developing novel hemostatic agents.
The geriatric population in Japan is increasing and is at a high risk of developing various diseases, including cancer, cardiovascular diseases, neurological disorders, obesity, and diabetes. According to the article published by the World Economic Forum in September 2023, over 10% of the population, or 1 in 10 individuals in Japan, are aged 80 or older. Elderly patients often need specialized care and are susceptible to injuries & slow-healing wounds. As the population leans toward a more active lifestyle, there has been a rise in the number of everyday injuries and wounds among this demographic. Chronic illnesses commonly lead to the need for surgical procedures in older patients, which further drives the Japan hemostats market expansion.
Furthermore, the rising incidences of cancer across Japan are expected to propel the market growth. According to the statistics published by the International Agency for Research On Cancer (IARC) for 2022, around 1,005,157 new cancer cases were reported in Japan in 2022. Furthermore, hemostats are widely used in cancer surgeries to control bleeding. Thus, the rising prevalence of cancer in Japan is anticipated to boost market growth.
The geriatric population in Japan is increasing and is at a high risk of developing various diseases, including cancer, cardiovascular diseases, neurological disorders, obesity, and diabetes. According to the article published by the World Economic Forum in September 2023, over 10% of the population, or 1 in 10 individuals in Japan, are aged 80 or older. Elderly patients often need specialized care and are susceptible to injuries & slow-healing wounds. As the population leans toward a more active lifestyle, there has been a rise in the number of everyday injuries and wounds among this demographic. Chronic illnesses commonly lead to the need for surgical procedures in older patients, which further drives the Japan hemostats market expansion.
Furthermore, the rising incidences of cancer across Japan are expected to propel the market growth. According to the statistics published by the International Agency for Research On Cancer (IARC) for 2022, around 1,005,157 new cancer cases were reported in Japan in 2022. Furthermore, hemostats are widely used in cancer surgeries to control bleeding. Thus, the rising prevalence of cancer in Japan is anticipated to boost market growth.
Japan Hemostats Market Report Highlights
- Oxidized regenerated cellulose-based hemostats segment dominated the product segment with more than 46.46% share in 2023 owing to the proven efficacy and widespread adoption of these hemostats
- The combination hemostats segment is expected to grow at the fastest CAGR over the forecast period
- Matrix and gel hemostats segment dominated the formulation segment. However, the sponge hemostats segment is anticipated to witness the fastest growth in the coming years
- Based on the application, the orthopedic surgery segment held the largest market share owing to the large number of orthopedic procedures being conducted in Japan. On the other hand, cardiovascular surgery segment is anticipated to grow fastest over the forecast period
- On the basis of end-use, the hospitals & clinics dominated the market with a revenue share of 63.37% in 2023. However, the ambulatory surgical centers are expected to register the fastest CAGR over the forecast period
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Japan Hemostats Market Variables, Trends & Scope
Chapter 4. Japan Hemostats Market: Product Estimates & Trend Analysis
Chapter 5. Japan Hemostats Market: Formulation Estimates & Trend Analysis
Chapter 6. Japan Hemostats Market: End-use Estimates & Trend Analysis
Chapter 7. Japan Hemostats Market: Application Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Johnson & Johnson Services, Inc.
- CryoLife, Inc
- Integra LifeSciences Corporation
- Cohera Medical, Inc.
- Pfizer
- Cohesion Technologies
- B. Braun Melsungen AG
- Baxter
- Medtronic
- BD
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 78 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 190.8 Million |
| Forecasted Market Value ( USD | $ 292.6 Million |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Japan |
| No. of Companies Mentioned | 10 |
